Home » Healthcare » Pharmaceuticals » Pain Therapeutics Market

Pain Therapeutics Market By Drug Class (Acetaminophen And Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Opioids, Anesthetics, Anticonvulsants, Corticosteroids, Antidepressants), By Pain Type (Nociceptive Pain, Neuropathic Pain, Psychogenic Pain) – Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Name: Pain Therapeutics Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2017-12-01
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Pain Therapeutics Market

Summary
Table Of Content
Request Sample

Market Insights:

Pain therapeutics are used to relieve the pain either by stopping the pain signals or by altering the brain’s interpretation of these signals. Pain therapeutics have the ability to reduce pain intensity but do not treat the cause of the pain. The global pain therapeutics market is anticipated to grow significantly over the forecast period due to the growing incidence of chronic and pain-inducing illnesses, the strong presence of ideal pipeline molecules, the growing number of surgeries, and the rising number of musculoskeletal diseases, inflammatory disease, trauma, and injuries to the internal organs.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

The report titled “Pain Therapeutics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers an in-depth understanding of the overall pain therapeutics market size for the duration of 2015–2025. The report study examines the pain therapeutics market segmentation by drug class (acetaminophen and nonsteroidal anti-inflammatory drugs; opioids; anesthetics; anticonvulsants; corticosteroids; antidepressants; others); and pain type (nociceptive pain, neuropathic pain, and psychogenic pain).

This study examined geographical market segments in depth. Regional and country-level markets are studied, including those in Europe (Germany, the United Kingdom, and the Rest of Europe), North America (Canada and the United States), Latin America (Mexico, Brazil, and the Rest of Latin America), Asia Pacific (China, Japan, and the Rest of APAC), the Middle East, and Africa (the GCC and the Rest of the Middle East and Africa).

Along with the statistical information, qualitative information is also included in the report for further understanding of the current market position and future market scenario. To provide information related to the ongoing trend of the market, in-depth information related to pain therapeutics market drivers, opportunities, and challenges are also included in this report. In addition, the competitive environment, information related to the market positioning of key manufacturers, and attractive investment propositions are also covered in this report.

Based on drug classes, the global pain therapeutics market is segmented as follows:

Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs)
Opioids
Anesthetics
Anticonvulsants
Corticosteroids
Antidepressants
Other

Pain therapeutics are used to relieve the pain either by stopping the pain signals or by altering the brain’s interpretation of these signals. The growing number of chronic diseases, the increasing number of surgeries, and the strong presence of pipeline drugs are the prime factors driving the growth of the pain therapeutics market globally. It is observed that the pain therapeutics market is saturated by a multitude of manufacturers, and thus, major players in the pain therapeutics market are trying to distinguish their products to avoid price competition. It has been studied that the demand for NSAIDs and opiates is the highest in the market due to their effectiveness in treating pain. Easy availability and an increase in the use of low-cost NSAIDs and acetaminophen in the treatment of different conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, arthritis, gout, minor injuries, joint pain, etc. are assisting the growth of the NSAIDs market globally.

According to the Centers for Disease Control and Prevention (CDC), approximately 2 million Americans aged 12 and up were dependent on prescription opioids or engaged in drug abuse in 2014. Stringent regulatory guidelines for the use of opiates such as oxycodone, hydrocodone, meperidine, hydromorphone, propoxyphene, etc., may negatively impact the growth of the global opioid drug market. The Drug Enforcement Administration (DEA) announced in 2017 that the number of opioid medications manufactured for sale and research in the United States would be reduced by 25% due to the rising death toll from an opioid overdose.

Based on the types of pain, the global pain therapeutics market is segmented as follows:

Nociceptive Pain

Somatic Pain
Visceral Pain
Cutaneous Pain

Neuropathic Pain

Psychogenic Pain

According to the National Center for Health Statistics, one in every four Americans is suffering from pain. It has been observed that the demand for nociceptive pain therapeutics is currently the highest in the market because it is the most common type of pain. The rising number of patients suffering from arthritis, myofascial pain, fibromyalgia, bone pain, fractures, joint pain, inflammation, trauma related to interior organs, etc., is driving the growth of the pain therapeutics market for nociceptive pain.

The demand for pain therapeutics used for treating neuropathic pain will show the fastest market growth over the forecast period due to the higher unmet needs, the strong presence of ideal pipeline molecules, and the growing number of conditions such as multiple sclerosis, multiple myeloma, diabetes, cancer, neuralgia, etc. The expected launch of pipeline drugs such as GRO-12, REGN-475, KRN-5500, XP-002, TV-45070, PF-04383119, and AGN-203818 would assist the growth of neuropathic pain therapeutics during the forecast period of 2017 to 2025.

For the purpose of this study, the global pain therapeutics market is categorized into three segments:

North America
- U.S.
- Canada
Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Among the considered geographical segments, North America is the current leader in the global pain therapeutics market. The United States dominates this region owing to key factors such as higher costs of pain-relieving therapeutics, an increase in the number of affected populations, an increase in the number of pain management centers, higher demand for pain therapeutics, and the easy availability of novel pain management drugs. According to the National Institutes of Health (NIH), approximately 100 million Americans, or one-third of the United States population, are affected by chronic pain. The key players in North America continue to focus on research and development activities and tend to provide ideal pain management therapeutics in the near future.

The expected launch of novel pain drugs such as GRO-12, REGN-475, KRN-5500, XPF-002, TV-45070, PF-04383119, AGN-203818, etc., would further assist market growth in North America. On the other hand, Asia Pacific is anticipated to show significant market growth over the forecast period due to the increasing penetration of key players in emerging markets such as China and India, increasing R&D investment, a large pool of patients, growing healthcare expenditure, and rising government funding and initiatives in healthcare systems.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Pain Therapeutics Market Portraiture
2.1.1. Global Pain Therapeutics Market, by Drug Class, 2016
2.1.2. Global Pain Therapeutics Market, by Pain Type, 2016
2.1.3. Global Pain Therapeutics Market, by Geography, 2016

Chapter 3. Pain Therapeutics: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2016
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Pipeline Analysis of Pain Therapeutics
4.1. Overview
4.2. Projected Sales of Phase III Pain Therapeutics Estimated Till 2025 (US$ Bn)
4.3. Tabular Representation of Phase II and I Pain Therapeutics

Chapter 5. Global Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
5.1. Overview
5.1.1. Attractive Investment Proposition, by Drug Class, 2016
5.2. Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
5.3. Opioids
5.4. Anesthetics
5.5. Anticonvulsants
5.6. Corticosteroids
5.7. Antidepressants
5.8. Other

Chapter 6. Global Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
6.1. Overview
6.2. Nociceptive Pain
6.2.1. Somatic Pain
6.2.2. Visceral Pain
6.2.3. Cutaneous Pain
6.3. Neuropathic Pain
6.4. Psychogenic Pain

Chapter 7. Global Pain Therapeutics Market, by Geography, 2015 – 2025
7.1. Overview
7.2. North America Pain Therapeutics Market Analysis, 2015 – 2025
7.2.1. North America Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.2.2. North America Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.2.3. North America Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.2.3.1. U.S.
7.2.3.2. Canada
7.3. Europe Pain Therapeutics Market Analysis, 2015 – 2025
7.3.1. Europe Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.3.2. Europe Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.3.3. Europe Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.3.3.1. U.K.
7.3.3.2. Germany
7.3.3.3. Rest of Europe
7.4. Asia Pacific Pain Therapeutics Market Analysis , 2015 – 2025
7.4.1. Asia Pacific Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.4.2. Asia Pacific Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.4.3. Asia Pacific Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.4.3.1. China
7.4.3.2. Japan
7.4.3.3. Rest of APAC
7.5. Latin America Pain Therapeutics Market Analysis , 2015 – 2025
7.5.1. Latin America Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.5.2. Latin America Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.5.3. Latin America Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.5.3.1. Brazil
7.5.3.2. Mexico
7.5.3.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Pain Therapeutics Market Analysis, 2015 – 2025
7.6.1. MEA Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.6.2. MEA Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.6.3. MEA Pain Therapeutics Market, by Region, 2015 – 2025 (US$ Bn)
7.6.3.1. GCC
7.6.3.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. AstraZeneca plc.
8.3. Biogen Idec Inc.
8.4. Bristol-Myers Squibb and Company
8.5. Depomed Inc.
8.6. Eli Lily and Company
8.7. GlaxoSmithKline PLC.
8.8. Johnson & Johnson Services Inc.
8.9. Mallinckrodt plc.
8.10. Merck & Co. Inc.
8.11. Novartis AG
8.12. Pfizer Inc.
8.13. Purdue Pharma L.P.
8.14. Sanofi S.A.
8.15. Other Notable Players

List of Figures

FIG. 1 Pain Therapeutics: Market Segmentation
FIG. 2 Global Pain Therapeutics Market, by Drug Class, 2016 (US$ Bn)
FIG. 3 Global Pain Therapeutics Market, by Pain Type, 2016 (US$ Bn)
FIG. 4 Global Pain Therapeutics Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market for Pain, 2015 – 2025 (US$ Bn)
FIG. 8 Global Opioids Market for Pain, 2015 – 2025 (US$ Bn)
FIG. 9 Global Anesthetics Market for Pain, 2015 – 2025 (US$ Bn)
FIG. 10 Global Anticonvulsants Market for Pain, 2015 – 2025 (US$ Bn)
FIG. 11 Global Corticosteroids Market for Pain, 2015 – 2025 (US$ Bn)
FIG. 12 Global Antidepressants for Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 13 Global Other Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 14 Global Somatic Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 15 Global Visceral Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 16 Global Cutaneous Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 17 Global Neuropathic Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 18 Global Psychogenic Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 19 U.S. Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 20 Canada Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 21 U.K. Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 22 Germany Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 23 Rest of Europe Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 24 Japan Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 25 China Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 26 Rest of Asia Pacific Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 27 Brazil Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 28 Mexico Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 29 Rest of Latin America Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 30 GCC Pain Therapeutics Market, 2015 – 2025 (US$ Bn)
FIG. 31 Rest of Middle East and Africa Pain Therapeutics Market, 2015 – 2025 (US$ Bn)

List of Tables

TABLE 1 Global Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 2 Global Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
TABLE 3 Global Nociceptive Pain Market, 2015 – 2025 (US$ Bn)
TABLE 4 North America Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 5 North America Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
TABLE 6 North America Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Europe Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 8 Europe Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
TABLE 9 Europe Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 10 Asia Pacific Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 11 Asia Pacific Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
TABLE 12 Asia Pacific Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Latin America Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 14 Latin America Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
TABLE 15 Latin America Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 16 Middle East and Africa Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 17 Middle East and Africa Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
TABLE 18 Middle East and Africa Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 19 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 AstraZeneca Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Biogen Idec Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Bristol-Myers Squibb and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Depomed Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Eli Lily and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 GlaxoSmithKline PLC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Johnson & Johnson Services Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Mallinckrodt Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Merck & Co. Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Purdue Pharma L.P. Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions:

What is the size of Pain Therapeutics Market?

The market for Pain Therapeutics Market is expected to reach US$ 85.4 Bn by 2025.

What is the Pain Therapeutics Market CAGR?

The Pain Therapeutics Market is expected to see significant CAGR growth over the coming years, at 5.3%.

What is the Forecast period considered for Pain Therapeutics Market?

The report is forecasted from 2017-2025.

What is the base year considered for Pain Therapeutics Market?

The base year of this report is 2016.

Who are the major players in this market?

Abbott Laboratories, AstraZeneca plc., Biogen Idec Inc., Eli Lily and Company are some of the major players in the global market.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Exterior Paint Retail Market

The exterior paint retail market size was valued at USD 38386 million in 2024 and is anticipated to reach USD 72109.2 million by 2032, at a CAGR of 8.2 % during the forecast period (2024-2032).

Veterinary Pain Management Market

The Veterinary Pain Management Market size was valued at USD 2,030.00 million in 2018 to USD 2,433.71 million in 2024 and is anticipated to reach USD 4,010.35 million by 2032, at a CAGR of 6.51% during the forecast period.

Paint Tester Market

The Paint tester market is projected to grow from USD 178 million in 2024 to an estimated USD 271 million by 2032, with a compound annual growth rate (CAGR) of 5.4% from 2024 to 2032.

Hybrid Paint Cans Market

The Hybrid paint cans market is projected to grow from USD 1248 million in 2024 to an estimated USD 1694 million by 2032, with a compound annual growth rate (CAGR) of 3.9% from 2024 to 2032.

Spain Electrophysiology Devices Market

Spain Electrophysiology Devices Market size was valued at USD 234.33 million in 2023 to USD 263.44 million in 2024 and is anticipated to reach USD 692.03 million by 2032, at a CAGR of 12.83% during the forecast period.

Automotive Paints Market

The Global Automotive Paints Market is projected to grow from USD 8,450 million in 2024 to an estimated USD 10,539 million based on 2032, with a compound annual growth rate (CAGR) of 2.8% from 2025 to 2032.

Spain Cardiovascular Devices Market

The Spain Cardiovascular Devices Market is projected to grow from USD1,469.93 million in 2024 to an estimated USD2,321.94 million by 2032, with a compound annual growth rate (CAGR) of 5.2% from 2025 to 2032.

Malaysia Chronic Pain Market

The Chronic Pain Market In Malaysia is expected to grow from USD 143.77 million in 2024 to USD 218.48 million by 2032, with a compound annual growth rate (CAGR) of 5.37%.

Spain Pea Proteins Market

The Spain Pea Proteins Market is projected to grow from USD 44.66 million in 2024 to an estimated USD 97.58 million by 2032, with a compound annual growth rate (CAGR) of 10.26% from 2024 to 2032.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample